Literature DB >> 23080419

Peripheral arterial disease: a literature review.

P Abdulhannan1, D A Russell, S Homer-Vanniasinkam.   

Abstract

INTRODUCTION: Peripheral arterial disease (PAD) is a common vascular condition that affects both quality of life and life expectancy with an increased risk of cardiovascular events. SOURCES OF DATA: A literature search was carried out of Pub-Med, MEDLINE, the Cochrane Library and Google Scholar from the establishment of these databases up to February 2012. The search was performed by using the keywords 'peripheral arterial disease' and one of the following words: 'management', 'investigations', 'risk factors', 'epidemiology', 'revascularization', 'cryoplasty', 'atherectomy' and 'gene therapy'. Studies were limited to those published in English language. AREAS OF AGREEMENT: Aggressive risk factors modification is needed to reduce cardiovascular-related mortality in PAD patients. AREAS OF CONTROVERSY: Choice of endovascular or surgical intervention remains controversial in an ever-evolving field. GROWING POINTS: There is a rapid expansion of endovascular technologies aiming to improve the effectiveness of this modality. AREAS TIMELY FOR DEVELOPING RESEARCH: The advances in the fields of gene therapy and therapeutic angiogenesis mean these are potential future treatments. Tissue engineering is a developing area and aims to produce grafts with similar patency and infection profiles to those of autologous material. Further elucidation of the pathophysiology of atherosclerosis is required to provide new targets for pharmacotherapy.

Entities:  

Mesh:

Year:  2012        PMID: 23080419     DOI: 10.1093/bmb/lds027

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  18 in total

1.  ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model.

Authors:  Carolina A Ferreira; Reinier Hernandez; Yunan Yang; Hector F Valdovinos; Jonathan W Engle; Weibo Cai
Journal:  Mol Pharm       Date:  2018-06-25       Impact factor: 4.939

2.  Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease.

Authors:  Magdalena Pilz; Elisabeth Kandioler-Honetz; Alfa Wenkstetten-Holub; Waltraud Doerrscheidt; Rudolf Mueller; Robert Wolfgang Kurz
Journal:  Wien Klin Wochenschr       Date:  2014-05-14       Impact factor: 1.704

3.  Symptomatic peripheral artery disease is associated with decreased long-term survival after coronary artery bypass: a contemporary retrospective analysis.

Authors:  Teruya Nakamura; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Shunsuke Saito; Daisuke Yoshioka; Shin Yajima; Shohei Yoshida; Yoshiki Sawa
Journal:  Surg Today       Date:  2016-07-21       Impact factor: 2.549

4.  Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles.

Authors:  Christopher G England; Hyung-Jun Im; Liangzhu Feng; Feng Chen; Stephen A Graves; Reinier Hernandez; Hakan Orbay; Cheng Xu; Steve Y Cho; Robert J Nickles; Zhuang Liu; Dong Soo Lee; Weibo Cai
Journal:  Biomaterials       Date:  2016-05-21       Impact factor: 12.479

Review 5.  Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion.

Authors:  Stéphanie Paradis; Anne-Laure Charles; Alain Meyer; Anne Lejay; James W Scholey; Nabil Chakfé; Joffrey Zoll; Bernard Geny
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-13       Impact factor: 4.249

Review 6.  Haemodynamics and Flow Modification Stents for Peripheral Arterial Disease: A Review.

Authors:  Efstratios Kokkalis; Nicolas Aristokleous; J Graeme Houston
Journal:  Ann Biomed Eng       Date:  2015-10-14       Impact factor: 3.934

7.  Growth hormone-releasing hormone promotes therapeutic effects of peripheral blood endothelial progenitor cells in ischemic repair.

Authors:  Z Li; N Zhang; L Zhu; J Nan; J Shen; Z Wang; Y Lin
Journal:  J Endocrinol Invest       Date:  2019-09-10       Impact factor: 4.256

8.  Attenuation of skeletal muscle and renal injury to the lower limb following ischemia-reperfusion using mPTP inhibitor NIM-811.

Authors:  David Garbaisz; Zsolt Turoczi; Peter Aranyi; Andras Fulop; Oliver Rosero; Edit Hermesz; Agnes Ferencz; Gabor Lotz; Laszlo Harsanyi; Attila Szijarto
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

9.  Invasively-treated incidence of lower extremity peripheral arterial disease and associated factors in Taiwan: 2000-2011 nationwide hospitalized data analysis.

Authors:  Nien-Tzu Chang; Chien-Lung Chan; Yu-Tzuen Lu; Jin-Chyr Hsu; Yuan-Nian Hsu; Dachen Chu; Nan-Ping Yang
Journal:  BMC Public Health       Date:  2013-12-01       Impact factor: 3.295

10.  The Tissue-Engineered Vascular Graft-Past, Present, and Future.

Authors:  Samand Pashneh-Tala; Sheila MacNeil; Frederik Claeyssens
Journal:  Tissue Eng Part B Rev       Date:  2015-10-08       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.